- Free from Publisher M Lajer, L Tarnow, A Jorsal, T Teerlink, HH … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a prospective observational follow-up
study including 397 type 1 diabetic patients with overt diabetic nephropathy
(243 men aged 42.1 ± 10.5 years, GFR 76 ± 34 ml/min per 1.73 m 2 ) and a ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org K Krzyzanowska, F Mittermayer, M Wolzt, G … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS— During a median follow-up of 21 (interquartile range 11–27) months,
84 events occurred in 48 patients. According to multivariate Cox regression
analysis, patients with baseline ADMA or CRP in the highest tertile had a ... Cited by 30 - Related articles - BL Direct - All 6 versions
K Krzyzanowska, F Mittermayer, N Shnawa, M … - Diabetic Medicine, 2007 - pt.wkhealth.com Results: ADMA was significantly increased in patients with micro- and
macroalbuminuria [median 0.61 (interquartile range 0.55-0.70) μmol/l and 0.62
(0.50-0.79) μmol/l, respectively] compared with those with ... Cited by 13 - Related articles - BL Direct - All 7 versions
T Teerlink, HH Parving, P Rossing, M Lajer, … - Am Diabetes Assoc 1Steno Diabetes Center, Gentofte, Denmark. 2Department of Clinical Chemistry,
VU, University Medical Center, Amsterdam, The Netherlands 3Department of Medical
Endocrinology, Rigshospitalet, University Hospital of Copenhagen, ... Related articles - All 2 versions
S Ueda, S Yamagishi, Y Matsumoto, K Fukami … - Clinical and Experimental Nephrology, 2007 - Springer Abstract Endothelial dysfunction due to the reduced bioavailability of nitric
oxide (NO) is involved in the course of atheroscle- rotic cardiovascular disease
as well as chronic kidney dis- ease (CKD). NO is synthesized from ... Cited by 8 - Related articles - BL Direct - All 3 versions
T Kawata, M Daimon, R Hasegawa, K Teramoto … - International Journal of Cardiology, 2009 - Elsevier Measurements of serum asymmetric dimethylarginine (ADMA), an endogenous nitric
oxide synthase inhibitor, and coronary flow velocity reserve (CFVR) using
transthoracic Doppler echocardiography were performed at baseline and after ... Cited by 5 - Related articles - All 17 versions
- ►diabetesjournals.org MT Malecki, A Undas, K Cyganek, B … - Diabetes Care, 2007 - Am Diabetes Assoc Decreased availability of nitric oxide (NO), which contributes to the
development of diabetes vascular complications (1), is partially related to
asymmetric dimethylarginine (ADMA). ADMA is an endogenous NO synthase ... Cited by 8 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org C Duckelmann, F Mittermayer, DG Haider, J … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2007 - Am Heart Assoc Methods and Results— 253 patients with symptomatic chronic HF and impaired
left ventricular function (median age 70 years, 202 males) were followed for a
median of 14.2 months (interquartile range 6.8 to 21.2). ADMA and ... Cited by 18 - Related articles - All 8 versions
- ►ahajournals.org [PDF] M Zeller, C Korandji, JC Guilland, P Sicard, C … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2008 - Am Heart Assoc Objective—Asymmetrical dimethylarginine (ADMA) is an endogenous competitive
inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients
with acute myocardial infarction (MI), we aimed to analyze the predictive ... Cited by 9 - Related articles - All 8 versions
- ►ahajournals.org F Scalera, J Martens-Lobenhoffer, A … - Hypertension, 2008 - Am Heart Assoc Telmisartan, in addition to blocking angiotensin (Ang) II type 1 receptor (AT 1
R), activates peroxisome proliferator activated receptor (PPAR ) signaling that
interferes with nitric oxide (NO) system. Because aging of endothelial ... Cited by 10 - Related articles - All 5 versions
